Biocartis
Lausanne · Founded 2007
About Biocartis
Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland.
Company Facts
- Founded: 2007
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $418.1M
- Funding stage: IPO
- Last round: Grant (Sep 2020)
- Ticker: ebr:BCART
- Website: biocartis.com
- Phone: 41 21 694 04 30
Industries & Categories
Biotechnology, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/biocartis-46558 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.